₹2,178.7
▼ -10.07 -0.46%
As of 21 Sept 2026 · delayed
NSE Listed · Healthcare
Hester Biosciences Limited (HESTERBIO)
20-day avg volume: 9K shares
- Healthy return on equity of 15.4%.
- Pays a dividend yield of 50.0%.
- Net profit is growing year over year.
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹84 Cr | ₹63 Cr | ₹82 Cr | ₹84 Cr | ₹71 Cr | ₹77 Cr | ₹100 Cr | ₹77 Cr |
| EBITDA | ₹17 Cr | ₹9 Cr | ₹8 Cr | ₹21 Cr | ₹17 Cr | ₹14 Cr | ₹25 Cr | ₹17 Cr |
| Net Profit | ₹8 Cr | ₹12 Cr | ₹1 Cr | ₹16 Cr | ₹14 Cr | ₹9 Cr | ₹16 Cr | ₹97 Cr |
| EPS | — | — | — | — | — | — | — | — |
| Metric | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹315 Cr | ₹77 Cr | ₹63 Cr | ₹65 Cr | ₹70 Cr | ₹94 Cr | ₹342 Cr | ₹73 Cr |
| EBITDA | ₹48 Cr | ₹13 Cr | ₹11 Cr | ₹11 Cr | ₹16 Cr | ₹32 Cr | ₹77 Cr | ₹21 Cr |
| Net Profit | ₹27 Cr | ₹10 Cr | ₹8 Cr | ₹7 Cr | ₹11 Cr | ₹26 Cr | ₹56 Cr | ₹15 Cr |
| EPS | 33.89 | — | — | — | — | — | 67.57 | — |
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹299 Cr | ₹387 Cr | ₹411 Cr | ₹562 Cr | ₹670 Cr | ₹662 Cr | ₹653 Cr | ₹678 Cr |
| Total Liabilities | ₹118 Cr | ₹180 Cr | ₹175 Cr | ₹295 Cr | ₹381 Cr | ₹359 Cr | ₹327 Cr | ₹310 Cr |
| Equity | ₹181 Cr | ₹206 Cr | ₹236 Cr | ₹267 Cr | ₹289 Cr | ₹303 Cr | ₹327 Cr | ₹368 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹64 Cr | ₹48 Cr | ₹72 Cr | ₹26 Cr | ₹32 Cr | ₹60 Cr | ₹76 Cr | ₹78 Cr |
| Investing | ₹-23 Cr | ₹-74 Cr | ₹-38 Cr | ₹-117 Cr | ₹-77 Cr | ₹-23 Cr | ₹-19 Cr | ₹-3 Cr |
| Financing | ₹3 Cr | ₹19 Cr | ₹-18 Cr | ₹112 Cr | ₹42 Cr | ₹-26 Cr | ₹-52 Cr | ₹-49 Cr |
| Free Cash Flow | ₹41 Cr | ₹-26 Cr | ₹31 Cr | ₹-70 Cr | ₹-46 Cr | ₹35 Cr | ₹55 Cr | ₹60 Cr |
Healthcare · Drug Manufacturers - Specialty & Generic
Hester Biosciences Limited manufactures and trades in veterinary vaccines and health products in India and internationally. It operates through two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers vaccines for peste des petits ruminants, goat pox, brucella, lumpy skin disease, contagious bovine pleuropneumonia, and contagious caprine pleuropneumonia for cattle, buffalo, sheep, and goats; and diagnostic services. In addition, the company provides animal healthcare products, such as biosecurity solutions, therapeutics, nutritional supplements, and specialised formulations to enhance animal wellness and productivity. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticides, grooming products, and anti-infective formulations; and healthcare products, such as immune boosters, gut health enhancers, farm hygiene, vitamins, minerals, and specialty feed supplements for critical needs comprising disease prevention, growth, and nutritional balance. Additionally, the company provides Silvectant, a hydrogen peroxide and silver nitrate solution for disinfection of poultry sheds; Hestbac, a probiotic supplement to control pathogenic bacteria; Hestflora, a combined probiotic and prebiotic formulation that supports gut health and performance; AmmoStop, a probiotic blend for odour control and respiratory comfort in poultry farms. It also offers INACTIVATED H9N2 vaccine for low pathogenic avian influenza; ICEFT RTU, a ceftiofur formulation for uterine and bacterial infections; and Inomilk Gel, an oral calcium supplement, as well as operates diagnostic labs for poultry. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Mehsana, India.
www.hester.in ↗As of 2026-06-30
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% | 53.7% |
| FIIs | 0.4% | 0.4% | 0.4% | 0.5% | 0.6% | 0.6% | 0.9% | 0.5% | 0.5% | 0.5% | 0.4% | 0.3% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 45.8% | 45.8% | 45.8% | 45.7% | 45.6% | 45.7% | 45.4% | 45.7% | 45.7% | 45.7% | 45.9% | 46% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 13,342 | 13,450 | 12,844 | 11,305 | 11,538 | 11,473 | 11,853 | 11,810 | 12,260 | 12,603 | 12,373 | 11,961 |
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
| Name | Category | Stake | Shares |
|---|---|---|---|
| Rajiv Dinesh Gandhi | Shareholding of Promoter and Promoter Group | 10.5% | 8,91,508 |
| Sanjiv Dinesh Gandhi | Shareholding of Promoter and Promoter Group | 8.2% | 6,97,820 |
| Nina Rajiv Gandhi | Shareholding of Promoter and Promoter Group | 8.2% | 6,96,340 |
| Shaila Bhupendra Gandhi | Shareholding of Promoter and Promoter Group | 5.8% | 4,91,300 |
| Ravin Gandhi | Shareholding of Promoter and Promoter Group | 4.7% | 4,03,320 |
| Bela Gandhi | Shareholding of Promoter and Promoter Group | 4.7% | 4,00,635 |
| Bhupendra Vithaldas Gandhi | Shareholding of Promoter and Promoter Group | 4.7% | 3,97,989 |
| Kuntal Hasmukhlal Shah | Public Shareholding | 3.2% | 2,69,897 |
| Biolink Healthcare Limited | Shareholding of Promoter and Promoter Group | 2.9% | 2,48,838 |
| Manish Jain | Public Shareholding | 2.9% | 2,45,248 |
| Anup Chandravadan Kapadia | Shareholding of Promoter and Promoter Group | 2.7% | 2,28,354 |
| Darshna Dinesh Kapadia | Public Shareholding | 1.8% | 1,53,600 |
| Sandeep Shantilal Gala | Public Shareholding | 1.3% | 1,10,942 |
| Vinay Shah | Public Shareholding | 1.3% | 1,08,900 |
| Manish Jain (huf) | Public Shareholding | 1.2% | 1,04,869 |
| Jagrut Prataprai Gandhi | Public Shareholding | 1.2% | 1,00,000 |
| Manish Prataprai Gandhi | Public Shareholding | 1.2% | 1,00,001 |
| Hester Coatings Llp | Shareholding of Promoter and Promoter Group | 0.8% | 64,000 |
| Hester Diagnostics Private Limited | Shareholding of Promoter and Promoter Group | 0.3% | 24,000 |
| Hetal Sanjiv Gandhi | Shareholding of Promoter and Promoter Group | 0.2% | 19,590 |
| Yash Rajiv Gandhi | Shareholding of Promoter and Promoter Group | 0.1% | 7,250 |
| Bhupendra Vithaldas Gandhi Huf | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Name | Designation | Year |
|---|---|---|
| Bhupendra V Gandhi | Chairman & Non Executive Dir. | 2026 |
| Rajiv D Gandhi | ED / MD / CEO / Promoter | 2026 |
| PRIYA RAJIV GANDHI | Executive Director | 2026 |
| Sanjiv D Gandhi | Non Executive Director | 2026 |
| Sandhya Patel | Independent Non Exe. Director | 2026 |
| Ashok Bhadakal | Independent Non Exe. Director | 2026 |
| Ameet Desai | Independent Non Exe. Director | 2026 |
| Anil Jain | Independent Non Exe. Director | 2026 |
| Jatin Yagneshbhai Trivedi | Independent Non Exe. Director | 2026 |
| Vinod Mali | Company Sec. & Compli. Officer | 2026 |
| Segment | Revenue | Share |
|---|---|---|
| Poultry Healthcare | ₹206 Cr | 70.6% |
| Animal Healthcare | ₹86 Cr | 29.4% |
| Region | Revenue | Share |
|---|---|---|
| In India | ₹261 Cr | 89.4% |
| Outside India | ₹31 Cr | 10.6% |
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 11 | 9 | 9 |
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-30 | Board Meetings | — |
| forthcoming | 2026-07-14 | Dividend (11/- per share) | Final |
| dividend | 2026-07-14 | ₹11 (110%) | Final |
| dividend | 2025-08-06 | ₹7 (70%) | Final |
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 34 | 0 | 0 | 7 | 3 | 44 |
| 2026 | 25 | 0 | 0 | 7 | 3 | 34 |
| 2026 | 9 | 0 | 0 | 0 | 0 | 9 |
2 recent disclosure(s)
1 disclosure(s)
📍 1st Flr PushpakPachvati Circle, Motilal Hirabhai Road, Ahmedabad, Gujarat, 380006
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search
